共 50 条
- [5] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis [J]. American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
- [7] Dupilumab provides clinically meaningful responses in adults with moderate-to-severe atopic dermatitis (AD): Results from LIBERTY AD CHRONOS study [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 61 - 61
- [8] Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (02): : 239 - 243
- [10] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 130 - 139